Cover Image
Market Research Report

Europe L-Carnitine Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Process ; Product ; Application

Published by The Insight Partners Product code 936619
Published Content info 110 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe L-Carnitine Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Process ; Product ; Application
Published: May 12, 2020 Content info: 110 Pages
Description

Title:
Europe L-Carnitine Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Process (Chemical Synthesis, Bio-process); Product (Food Grade, Pharmaceutical Grade, Feed Grade); Application (Animal Feed, Healthcare Products, Functional Drinks, Medicines).

The L-Carnitine market was valued at US$ 47.1 million in 2018 and is projected to reach US$ 72.7 million by 2027; it is expected to grow at a CAGR of 4.9% from 2019 to 2027.

L-Carnitine is a naturally occurring compound in human and animal bodies; it plays an important role of shuttling fatty acids to and fro in the cells to produce energy. It is produced in the liver and kidneys. However, certain individuals are unable to produce or synthesize required amount of L-Carnitine owing to genetic conditions or defects. Such individuals suffer from primary and secondary L-Carnitine deficiency. The US Food and Drug Administration (FDA) has approved the use of oral and intravenous (IV) L-Carnitine for treating primary and secondary Carnitine deficiency. L-Carnitine is today commercially advertised as nutritional supplements to enhance exercise performance and promote weight loss. It is also approved to treat Carnitine deficiencies in patients at the end stage of renal diseases, undergoing hemodialysis.. Besides its uses in human nutrition, L-Carnitine is also used as an additive in animal feed formulations. It is used in the poultry industry to increase egg production and improve egg hatchability.

The L-Carnitine market, based on product, is segmented into food grade, pharmaceutical grade, and feed grade. In 2018, the food grade segment accounted for the largest share of the Europe L-Carnitine market, whereas the pharmaceutical grade segment is expected to register the fastest CAGR during the forecast period. L-Carnitine mainly carries out two functions-the first is the transportation of fatty acids into mitochondria, where they are burned and oxidized to produce energy, and the rest is the transportation of waste and toxic compounds out of mitochondria, thus preventing unwanted substances getting accumulated in the body. The consumption of L-Carnitine assists in the treatment of heart conditions such as heart failure or heart attack, angina, and diabetic neuropathy. Besides this, L-Carnitine acts as an antioxidant that rules out harmful free radicals from body, which otherwise can lead to severe cell damage.

The L-Carnitine market has been segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. Germany held the largest share of the European L-Carnitine market, followed by France and the UK. The growing focus on health-promoting food products is one of the key factors boosting the L-Carnitine market. The presence of several manufacturers such as ChengDa Pharmaceuticals Co., Ltd; Maxsun Industries Incorporated; Alpsure Lifesciences Pvt. Ltd; Lonza Group Ltd; Northeast Pharmaceutical Group Co., Ltd; Merck KGaA; and Biosint S.p.A., has bolstered the growth of the L-Carnitine market. Also, the consumer demand for healthy and nutritious products without any compromise on taste is expected to propel the growth of the L-Carnitine market in the region. Further, the growth of healthcare, food processing, and other industries is boosting the demand for L-Carnitine in this region.

Impact of COVID-19 Pandemic on L-Carnitine Market

The recent COVID-19 outbreak began in Wuhan (China) in December 2019, and since then it has spread across the globe at a fast pace. China, Italy, Iran, Spain, the Republic of Korea, France, Germany, and the US are among the worst affected countries in terms confirmed cases and reported deaths as of March 2020. The COVID-19 outbreak has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The overall dip in the global market due to COVID-19 is also affecting the growth of the L-Carnitine market due to factory shutdowns, supply chain discontinuation, and economic downturns.

ChengDa PharmaCeuticals Co., Ltd; Maxsun Industries Incorporated; Alpsure Lifesciences Pvt. Ltd; Lonza Group Ltd; Northeast Pharmaceutical Group Co., Ltd; Merck KGaA; and Biosint S.p.A., are among the major players in the European L-Carnitine market.

The overall Europe L-Carnitine market size has been derived in accordance to both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants who typically take part in such a process include industry expert such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the L-Carnitine market.

Reasons to Buy

  • Highlights key business priorities to assist companies realign their business strategies.
  • Featureskey findings and crucial progressive industry trends in the Europe L-Carnitine market, thereby allowing players to develop effective long-term strategies.
  • Develops/modifiesbusiness expansion plans by using substantial growth offering from developed and emerging markets.
  • Scrutinizes in-depth market trends as well as key market drivers and restraints.
  • Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.
Table of Contents
Product Code: TIPRE00010849

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe L-Carnitine Market - By Process
    • 1.3.2 Europe L-Carnitine Market - By Product
    • 1.3.3 Europe L-Carnitine Market - By Application
    • 1.3.4 Europe L-Carnitine Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. L-Carnitine Market Landscape

  • 4.1 Market Overview
  • 4.2 PEST Analysis - Europe
  • 4.3 Expert Opinions

5. L-Carnitine Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Demand for L-Carnitine Supplements to Enable Efficient Conversion of Food into Energy
    • 5.1.2 Rising Demand for Personalized Nutrition, Heart Health, and Athletic Performance
  • 5.2 Market Restraints
    • 5.2.1 Adverse Effects of L-Carnitine
  • 5.3 Market Opportunities
    • 5.3.1 Burgeoning consumption of L-Carnitine Across Europe
  • 5.4 Future Trends
    • 5.4.1 Growing Demand for L-Carnitine as Additive in Animal Feed
  • 5.5 Impact Analysis of Drivers and Restraints

6. Europe L - Carnitine Market Analysis - By Product

  • 6.1 Overview
  • 6.2 Europe L-Carnitine Market Breakdown, By Product, 2018 & 2027
  • 6.3 Food
    • 6.3.1 Overview
    • 6.3.2 Europe L-Carnitine Market in Food Segment: Revenue and Forecasts to 2027 (US$ Mn)
    • 6.3.3 Overview
    • 6.3.4 Europe L-Carnitine Market in Pharmaceutical Grade Segment: Revenue and Forecasts to 2027 (US$ Mn)
  • 6.4 Feed Grade
    • 6.4.1 Overview
    • 6.4.2 Europe L-Carnitine Market in Feed Grade Segment: Revenue Forecasts to 2027 (US$ Mn)

7. Europe L-Carnitine Market Analysis - By Application

  • 7.1 Overview
  • 7.2 Europe L-Carnitine Market Breakdown, By Application, 2018 & 2027
  • 7.3 Animal Feed
    • 7.3.1 Overview
    • 7.3.2 Europe L-Carnitine Market in Animal Feed Segment: Revenue and Forecasts to 2027 (US$ Mn)
  • 7.4 Healthcare Products
    • 7.4.1 Overview
    • 7.4.2 Europe L-Carnitine Market in Healthcare Products Segment: Revenue and Forecasts to 2027 (US$ Mn)
  • 7.5 Functional Drinks
    • 7.5.1 Overview
    • 7.5.2 Europe L-Carnitine Market in Functional Drinks Segment: Revenue and Forecast to 2027 (US$ Mn)
  • 7.6 Medicines
    • 7.6.1 Overview
    • 7.6.2 Europe L-Carnitine Market in Medicines Segment: Revenue and Forecast to 2027 (US$ Mn)

8. Carnitine Market Analysis - By Process

  • 8.1 Overview
  • 8.2 L-Carnitine Market, by Process, (2018 & 2027)
  • 8.3 Chemical Synthesis
    • 8.3.1 Overview
    • 8.3.2 Europe L-Carnitine Market in Chemical Synthesis Segment: Revenue and Forecast to 2027 (US$ Mn)
  • 8.4 Bioprocess
    • 8.4.1 Overview
    • 8.4.2 Europe L-Carnitine Market in Bioprocess Segment: Revenue and Forecast to 2027 (US$ Mn)

9. L-Carnitine- Europe Market Analysis

  • 9.1 Europe L-Carnitine Market Overview
    • 9.1.1 Europe: L Carnitine Market -Revenue and Forecast to 2027(US$ Mn)
    • 9.1.2 Europe: L Carnitine Market, by Process
    • 9.1.3 Europe: L Carnitine Market, by Product
    • 9.1.4 Europe: L Carnitine Market, by Application
    • 9.1.5 Europe: L Carnitine Market, by Key Country
      • 9.1.5.1 Germany: L Carnitine Market -Revenue and Forecast to 2027 (US$ Mn)
        • 9.1.5.1.1 Germany: L Carnitine Market, by Process
        • 9.1.5.1.2 Germany: L Carnitine Market, by Product
        • 9.1.5.1.3 Germany: L Carnitine Market, by Application
      • 9.1.5.2 France: L Carnitine Market -Revenue and Forecast to 2027 (US$ Mn)
        • 9.1.5.2.1 France: L Carnitine Market, by Process
        • 9.1.5.2.2 France: L Carnitine Market, by Product
        • 9.1.5.2.3 France: L Carnitine Market, by Application
      • 9.1.5.3 UK: L Carnitine Market -Revenue and Forecast to 2027 (US$ Mn)
        • 9.1.5.3.1 UK: L Carnitine Market, by Process
        • 9.1.5.3.2 UK: L Carnitine Market, by Product
        • 9.1.5.3.3 UK: L Carnitine Market, by Application
      • 9.1.5.4 Spain: L Carnitine Market -Revenue and Forecast to 2027 (US$ Mn)
        • 9.1.5.4.1 Spain: L Carnitine Market, by Process
        • 9.1.5.4.2 Spain: L Carnitine Market, by Product
        • 9.1.5.4.3 Spain: L Carnitine Market, by Application
      • 9.1.5.5 Italy: L Carnitine Market -Revenue and Forecast to 2027 (US$ Mn)
        • 9.1.5.5.1 Italy: L Carnitine Market, by Process
        • 9.1.5.5.2 Italy: L Carnitine Market, by Product
        • 9.1.5.5.3 Italy: L Carnitine Market, by Application
      • 9.1.5.6 Rest of Europe: L Carnitine Market -Revenue and Forecast to 2027 (US$ Mn)
        • 9.1.5.6.1 Rest of Europe: L Carnitine Market, by Process
        • 9.1.5.6.2 Rest of Europe: L Carnitine Market, by Product

10. Overview- Impact of COVID-19 Outbreak

11. Impact of COVID-19 Pandemic on Europe L-Carnitine Market

  • 11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

  • 12.1 Cayman Chemical
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
      • 12.1.2.1 Products and Services
    • 12.1.3 Financial Overview
    • 12.1.4 SWOT Analysis
  • 12.2 MERCK KGaA
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
      • 12.2.2.1 Products and Services
    • 12.2.3 Financial Overview
    • 12.2.4 SWOT Analysis
    • 12.2.5 Key Developments
  • 12.3 ChengDaPharmaCeuticals Co., Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
  • 12.4 Maxsun Industries Incorporated
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
      • 12.4.2.1 Products and Services
    • 12.4.3 Financial Overview
    • 12.4.4 SWOT Analysis
  • 12.5 Lonza Group Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
      • 12.5.2.1 Products and Services
    • 12.5.3 Financial Overview
    • 12.5.4 SWOT Analysis
    • 12.5.5 Key Developments
  • 12.6 Northeast Pharmaceutical Group Co., Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
      • 12.6.2.1 Products and Services
    • 12.6.3 Financial Overview
    • 12.6.4 SWOT Analysis
  • 12.7 ALPSURE LIFESCIENCES PVT. LTD.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products And Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
  • 12.8 BiosintS.p.A.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
      • 12.8.2.1 Products and Services
    • 12.8.3 Financial Overview
    • 12.8.4 SWOT Analysis

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary

LIST OF TABLES

  • Table 1. Europe L Carnitine Market, by Process - Revenue and Forecast to 2027 (USD Mn)
  • Table 2. Europe L Carnitine Market, by Product- Revenue and Forecast to 2027 (USD Mn)
  • Table 3. Europe L Carnitine Market, by Application - Revenue and Forecast to 2027 (USD Mn)
  • Table 4. Germany LCarnitine Market, by Process - Revenue and Forecast to 2027 (USD Mn)
  • Table 5. Germany LCarnitine Market, by Fiber Type - Revenue and Forecast to 2027 (USD Mn)
  • Table 6. Germany L Carnitine Market, by Application - Revenue and Forecast to 2027 (USD Mn)
  • Table 7. France L Carnitine Market, by Process - Revenue and Forecast to 2027 (USD Mn)
  • Table 8. France L Carnitine Market, by Product - Revenue and Forecast to 2027 (USD Mn)
  • Table 9. France L Carnitine Market, by Application - Revenue and Forecast to 2027 (USD Mn)
  • Table 10. UKL Carnitine Market, by Process - Revenue and Forecast to 2027 (USD Mn)
  • Table 11. UKL Carnitine Market, by Product- Revenue and Forecast to 2027 (USD Mn)
  • Table 12. UK L Carnitine Market, by Application - Revenue and Forecast to 2027 (USD Mn)
  • Table 13. Spain L Carnitine Market, by Process - Revenue and Forecast to 2027 (USD Mn)
  • Table 14. Spain L Carnitine Market, by Product- Revenue and Forecast to 2027 (USD Mn)
  • Table 15. Spain L Carnitine Market, by Application - Revenue and Forecast to 2027 (USD Mn)
  • Table 16. Italy L Carnitine Market, by Process - Revenue and Forecast to 2027 (USD Mn)
  • Table 17. Italy L Carnitine Market, by Product - Revenue and Forecast to 2027 (USD Mn)
  • Table 18. Italy L Carnitine Market, by Application - Revenue and Forecast to 2027 (USD Mn)
  • Table 19. Rest of Europe L Carnitine Market, by Process- Revenue and Forecast to 2027 (USD Mn)
  • Table 20. Rest of Europe L Carnitine Market, by Product- Revenue and Forecast to 2027 (USD Mn)
  • Table 21. Rest of Europe L Carnitine Market, by Application - Revenue and Forecast to 2027 (USD Mn)
  • Table 22. Glossary of Terms, Europe L-carnitine Market

LIST OF FIGURES

  • Figure 1. Europe L-Carnitine Market Segmentations
  • Figure 2. Europe L-Carnitine Market Segmentation - By Country
  • Figure 3. Europe L-Carnitine Market Overview
  • Figure 4. Market Food Segment Held Larger Share of L-Carnitine Market in 2018
  • Figure 5. Germany Dominated the Europe L-Carnitine Market In 2018
  • Figure 6. Europe L-Carnitine Market, Industry Landscape
  • Figure 7. Europe- PEST Analysis
  • Figure 8. Expert Opinion
  • Figure 9. Europe L-Carnitine Market Impact Analysis of Driver and Restraints
  • Figure 10. Europe L-Carnitine Market Breakdown By Product, Value, 2018 & 2027 (%)
  • Figure 11. Europe L-Carnitine Market in Food Segment: Revenue and Forecasts to 2027
  • Figure 12. Europe L-Carnitine Market in Pharmaceutical Grade Segment: Revenue and Forecasts To 2027 (US$ Mn)
  • Figure 13. Europe L-Carnitine Market in Feed Grade Segment: Revenue and Forecasts To 2027 (US$ Mn)
  • Figure 14. Europe L-Carnitine Market Breakdown By Application, Value, 2018 & 2027 (%)
  • Figure 15. Europe L-Carnitine Market in Animal Feed Segment: Revenue and Forecasts To 2027 (US$ Mn)
  • Figure 16. Europe L-Carnitine Market in Healthcare Products Segment: Revenue and Forecasts To 2027 (US$ Mn)
  • Figure 17. Europe L-Carnitine Market in Functional Drinks Segment: Revenue and Forecast to 2027 (US$ Mn)
  • Figure 18. Europe L-Carnitine Market in Medicines Segment: Revenue and Forecast to 2027 (US$ Mn)
  • Figure 19. L-Carnitine Breakdown, by Process, 2018 & 2027 (%)
  • Figure 20. Europe L-Carnitine Market in Chemical Synthesis Segment: Revenue and Forecast to 2027 (US$ Mn)
  • Figure 21. Europe L-Carnitine Market in Bioprocess Segment: Revenue and Forecast to 2027 (US$ Mn)
  • Figure 22. Europe: L Carnitine Market - Revenue and Forecast to 2027 (US$ Mn)
  • Figure 23. Europe: L Carnitine Market Revenue Share, by Process (2018 and 2027)
  • Figure 24. Europe: L Carnitine Market Revenue Share, by Product (2018 and 2027)
  • Figure 25. Europe: L Carnitine Market Revenue Share, by Application (2018 and 2027)
  • Figure 26. Europe: L Carnitine Market Revenue Share, by Key Country (2018 and 2027)
  • Figure 27. Germany: L Carnitine Market -Revenue and Forecast to 2027 (US$ Mn)
  • Figure 28. France: L Carnitine Market -Revenue and Forecast to 2027 (US$ Mn)
  • Figure 29. UK: L Carnitine Market -Revenue and Forecast to 2027 (US$ Mn)
  • Figure 30. Spain: L Carnitine Market -Revenue and Forecast to 2027 (US$ Mn)
  • Figure 31. Italy: L Carnitine Market -Revenue and Forecast to 2027 (US$ Mn)
  • Figure 32. Rest of Europe: L Carnitine Market -Revenue and Forecast to 2027 (US$ Mn)
  • Figure 33. Impact of COVID-19 Pandemic In Europe Country Markets
Back to Top